SALLY CAMPBELL: Open Payments
NPI 1134628217 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,910 in 85 payments from 15 companies in 2025. Trend: 2023 $3,169 · 2024 $1,306 · 2025 $1,910
Food & beverage: $1,810Education: $100
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $281 |
| Lilly USA, LLC | 7 | $269 |
| UCB, Inc. | 11 | $237 |
| ABBVIE INC. | 9 | $204 |
| Janssen Biotech, Inc. | 6 | $191 |
| PFIZER INC. | 17 | $156 |
| Regeneron Healthcare Solutions, Inc. | 5 | $142 |
| LEO Pharma Inc. | 3 | $73 |
| Novartis Pharmaceuticals Corporation | 3 | $68 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $65 |
Products named: DUPIXENT, Bimzelx, EBGLYSS, TREMFYA, SKYRIZI, CIBINQO, ANZUPGO, TALTZ.
Industry payments across NE — which companies pay providers there.
